Group 1 - The core point of the article is that Xiaofang Pharmaceutical (603207.SH) reported its Q3 2025 results, highlighting significant institutional ownership and changes in public fund disclosures [1] - As of October 24, 2025, a total of 9 institutional investors hold shares in Xiaofang Pharmaceutical, amounting to 113 million shares, which represents 70.24% of the total share capital [1] - The institutional ownership decreased by 1.14 percentage points compared to the previous quarter [1] Group 2 - One new public fund was disclosed this period, namely the GF Multi-Dimensional Emerging Stock Fund [1] - A total of 121 public funds were not disclosed this period compared to the previous quarter, including several notable funds such as CITIC Securities Rotation Mixed A and CITIC Securities Selected Mixed A [1] Group 3 - In terms of foreign investment, one new foreign institution was disclosed, which is Yunjia Far East Co., Ltd [2] - The same foreign institution, Yunjia Far East Co., Ltd, was not disclosed in the previous quarter [2]
机构风向标 | 小方制药(603207)2025年三季度已披露前十大机构持股比例合计下跌1.14个百分点